Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Mezoteliomi
Authors:ID Kovač, Viljem (Author)
Files:.pdf PDF - Presentation file, download (766,87 KB)
MD5: 7D4D66FDAFACEF4A8C397168E68C0F02
PID: 20.500.12556/dirros/72379b93-6deb-4766-9bc9-b4ecdd87f5fb
 
Language:Slovenian
Typology:1.02 - Review Article
Organization:Logo OI - Institute of Oncology
Abstract:Maligni mezoteliom uvrščamo med redke rake, njegova incidenca pa še vedno narašča pri nas in v svetu. V Sloveniji smo zakonsko prepovedali proizvodnjo in uporabo azbesta leta 1996, vendar še nismo zmanjšali bremena te bolezni, ker je latentni čas med izpostavljenostjo azbestu ter obolevnostjo zelo dolg. Različne klinične raziskave so potrdile učinkovitost sistemskega zdravljenja, kot sta kombinaciji cisplatina in gemcitabina ter cisplatina in pemetrekseda. Do sedaj smo samo na Nizozemskem in v Sloveniji dokazali, da je sodobno kemoterapevtsko zdravljenje statistično značilno podaljšalo srednje celokupno preživetje celotne populacije bolnikov s to boleznijo.
Keywords:pljučni rak, mezoteliomi, maligni mezoteliomi
Publication status:Published
Publication version:Version of Record
Year of publishing:2012
Number of pages:str. 64-68, 112
Numbering:Letn. 16, št. 2
PID:20.500.12556/DiRROS-8886 New window
UDC:616.24-006.6
ISSN on article:1408-1741
URN:URN:NBN:SI:doc-P3YFBUJP
COBISS.SI-ID:1422459 New window
Copyright:by Authors
Publication date in DiRROS:31.08.2018
Views:3654
Downloads:1089
Metadata:XML DC-XML DC-RDF
:
KOVAČ, Viljem, 2012, Mezoteliomi. Onkologija [online]. 2012. Vol. 16, no. 2, p. 64–68, 112. [Accessed 4 April 2025]. Retrieved from: https://dirros.openscience.si/IzpisGradiva.php?lang=eng&id=8886
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija
Shortened title:Onkologija
Publisher:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Language:English
Title:Mesotheliomas
Abstract:Malignant mesothelioma is a rare type of cancer, the incidence of which is still increasing both in our country and also throughout the world. In Slovenia, the production and use of asbestos was prohibited in 1996, but we have not yet managed to reduce the burden of this disease due to the extremely long latency period between exposure to asbestos and incidence of the disease. Different clinical trials confirmed the effectiveness of systemic treatment, such as the combination of cisplatin and gemcitabin and the combination of cisplatin and pemetrexed. So far, only the Netherlands and Slovenia have managed to prove that modern chemotherapy treatment statistically significantly prolonged the median overall survival of the entire population of patients with this disease.


Archive

niGradiv

Back